Research Progress of the Role of EMT in EGFR-TKIs Resistance 
of Non-small Cell Lung Cancer

Lung cancer is the one of the malignant tumor of the highest morbidity and mortality over the world, and non-small cell lung cancer (NSCLC) makes up about 80%. Nowadays, molecular targeted therapy has been the first-line treatment for NSCLC. Epidermal growth factor receptor-tyrosine kinase inhibitor...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Li YU, Sha HUANG, Wang LV, Zhehao HE, Jian HU
Formato:	Artigo
Idioma:	Chinês
Publicado em:	Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2018-12-01
Colecção:	Chinese Journal of Lung Cancer
Assuntos:	Lung neoplasms EGFR-TKIs resistance Epithelial-mesenchymal transition Regulatory mechanism
Acesso em linha:	http://dx.doi.org/10.3779/j.issn.1009-3419.2018.12.08
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!